Journal Mobile Options
Table of Contents
Vol. 26, No. 4, 2009
Issue release date: December 2009
Section title: Original Paper
Fetal Diagn Ther 2009;26:181–184

Twin Pregnancy Presenting as a Praevia Complete Hydatidiform Mole and Coexisting Fetus Complicated by a Placental Abscess

Suri S. · Davies M. · Jauniaux E.
Department of Obstetrics and Gynaecology, University College London Hospitals, London, UK
email Corresponding Author

Eric Jauniaux

Academic Department of Obstetrics and Gynaecology

EGA Institute for Women’s Health, University College London

86–96 Chenies Mews, London WC1E 6HX (UK)

Tel. +44 207 209 6053, Fax +44 207 383 7429, E-Mail

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.


Background: A twin pregnancy consisting of a complete hydatidiform mole and a coexisting normal fetus (CMCF) is a rare and challenging condition when diagnosed prenatally and is associated with major obstetric complications. Case Report: We present a case of CMCF in which the molar component presented as a major placenta praevia at 19 weeks, and which was complicated by a placental abscess with maternal septicaemia from 26 weeks. An emergency caesarean section, performed at 28 weeks’ gestation due to severe maternal septicaemia, resulted in the delivery of a live male infant. Despite the molar mass being praevia, the delivery was not complicated by extensive haemorrhage. Conclusion: This is only the second case of CMCF complicated by a molar praevia and the first complicated by a placental abscess. We believe that the 2 conditions are linked and that the absence of normal fetal membranes surrounding the molar mass enabled secondary colonization by vaginal bacteria. Therefore, we recommend that immediate antibiotic treatment is initiated in cases of CMCF presenting as a praevia when maternal and/or fetal symptoms of infection develop.

© 2009 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 7/6/2009
Accepted: 8/16/2009
Published online: 10/27/2009

Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 0

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information:

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.